Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Genes & Development
|
January 19, 2017
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
Paola Falletta, Luis Sanchez-Del-Campo, Jagat Chauhan, et al.
British Journal of Cancer
|
November 6, 2022
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer
Giuseppe Curigliano, Geoffrey I Shapiro, Rebecca S Kristeleit, et al.
Molecular Cell
|
June 13, 2020
Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution
Pakavarin Louphrasitthiphol, Robert Siddaway, Alessia Loffreda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2019
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019
Claus Garbe, Teresa Amaral, Ketty Peris, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 17, 2019
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)
Celeste Lebbe, Claus Garbe, Alexander J Stratigos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 14, 2020
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019
Claus Garbe, Teresa Amaral, Ketty Peris, et al.
Cancer Chemotherapy and Pharmacology
|
October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours
Laura Horsley, Jeff Cummings, Mark Middleton, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2023
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF<sup>V600</sup> mutant advanced melanoma (INTERIM)
Alimu Dayimu, Avinash Gupta, Rubeta N Matin, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2024
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Jason J Luke, Diwakar Davar, Robert H Andtbacka, et al.
The Journal of Animal Ecology
|
October 23, 2025
An integrative, peer-reviewed and open-source cooperative-breeding database (Co-BreeD)
Yitzchak Ben Mocha, Maike Woith, Sophie Scemama de Gialluly, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Genes & Development
|
January 19, 2017
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
Paola Falletta, Luis Sanchez-Del-Campo, Jagat Chauhan, et al.
British Journal of Cancer
|
November 6, 2022
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer
Giuseppe Curigliano, Geoffrey I Shapiro, Rebecca S Kristeleit, et al.
Molecular Cell
|
June 13, 2020
Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution
Pakavarin Louphrasitthiphol, Robert Siddaway, Alessia Loffreda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2019
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019
Claus Garbe, Teresa Amaral, Ketty Peris, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 17, 2019
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)
Celeste Lebbe, Claus Garbe, Alexander J Stratigos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 14, 2020
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019
Claus Garbe, Teresa Amaral, Ketty Peris, et al.
Cancer Chemotherapy and Pharmacology
|
October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours
Laura Horsley, Jeff Cummings, Mark Middleton, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2023
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF<sup>V600</sup> mutant advanced melanoma (INTERIM)
Alimu Dayimu, Avinash Gupta, Rubeta N Matin, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2024
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Jason J Luke, Diwakar Davar, Robert H Andtbacka, et al.
The Journal of Animal Ecology
|
October 23, 2025
An integrative, peer-reviewed and open-source cooperative-breeding database (Co-BreeD)
Yitzchak Ben Mocha, Maike Woith, Sophie Scemama de Gialluly, et al.
Page
of 6